Chain Drug Review, February 4, 2019

6 Chain Drug Review February 4 2019 News WBA joins with Microsoft in health care partnership As part of the strategic partnership the companies have committed to a multiyear research and development investment to build health care solutions improve health outcomes and lower the cost of care This investment will include funding subject matter experts technology and tools The companies will also explore the potential to establish joint innovation centers in key markets Additionally in 2019 WBA will pilot up to 12 store in store digital health corners aimed at the merchandising and sale of selected health care related hardware and devices Our strategic partnership with Microsoft demonstrates our strong commitment to creating integrated next generation digitally enabled health care delivery solutions for our customers transforming our stores into modern neighborhood health destinations and expanding customer offerings said Stefano Pessina executive vice chairman and chief executive officer of WBA WBA will work with Microsoft WHAT WE DO MAKES A DIFFERENCE In the new and emerging hemp CBD market many brands claim to be the best or the most trusted As a buyer it can be hard to know who to believe or what to choose Being natural products industry experts we know its more than just the products that matter Thats why at PlusCBD Oil what we do is truly different Vertically Integrated Offering Full Traceability From Seed to Shelf cGMP Auditable QA QC Laboratory Independent Third Party and DNA Testing QR Codes on Every Label for Increased Transparency Human Clinical Testing Proving Efficacy Generally Recognized as Safe GRAS Self Determination Expertise History in the Dietary Supplements Industry Members of Essential Trade Organizations Unparalleled Education Sales and Marketing Support Widest Product Selection Available THE 1 SELLING HEMP CBD PRODUCTS 855 OUR HEMP I NPIORDERS@ CVSCIENCES COM A CV SCIENCES BRAND BASED ON SPINS SCAN DATA TM HEMP DERIVED CBD OIL to harness the information that exists between payors and health care providers to leverage in the interest of patients and with their consent our extraordinary network of accessible and convenient locations to deliver new innovations greater value and better health outcomes in health care systems across the world The companies will focus on connecting WBA stores and health information systems to people wherever they are through their digital devices This will allow people to access health care services such as virtual care when where and how they need it The integration of information will enable valuable insights based on data science and AI that can allow for fundamental improvements such as supporting the transition of health care data into more community based locations and sustainable transformation in health care delivery Working with patients health care providers the companies will proactively engage their patients to improve medication adherence reduce emergency room visits and decrease hospital readmissions Core to this model is data privacy security and consent which will be fundamental design principles underscored by Microsofts investments in building a trusted cloud platform By better connecting people providers and the systems in which they work the industry will be able to provide betterquality patient care WBA and Microsoft will also focus on enabling more personalized health care experiences from preventative self care to chronic disease management WBA will pursue lifestyle management solutions in areas such as nutrition and wellness via customers delivery method of choice including digital devices and digital applications or in store expert advice Continued from page 1 Hy Vee adopts new opioid policy WEST DES MOINES Iowa To assist in combatting the national opioid epidemic Hy Vee Inc has implemented a new controlled substance prescription policy Since January 1 Hy Vee pharmacies have not allowed a subsequent fill of a Schedule II controlled substance or a refill of a Schedule III or Scheduled IV controlled substance more than 72 hours early without authorization from the prescriber The opioid epidemic in the United States claims the lives of more than 100 people every day and Hy Vee is continually working to assist in the fight said Kristin Williams senior vice president and chief health officer for Hy Vee Implementing this 72 hour policy is one more step toward combatting the opioid epidemic in communities throughout the eight states we serve Hy Vee already offers naloxone without a prescription in all eight states where it operates pharmacies Illinois Iowa Kansas Minnesota Missouri Nebraska South Dakota and Wisconsin Naloxone is available at Hy Vee pharmacies in nasal spray and injection forms upon request although nasal spray is the most commonly used form The drug is stored behind the counter and cost varies depending on the form and whether customers go through their insurance or pay cash Hy Vee pharmacists also ensure that patients and their family members understand how to recognize signs of an opioid overdose and how to administer the medication While naloxone is not a cure for an opioid overdose it can assist an individual until emergency treatment is available and longterm treatment is provided The medication has no effect if opioids are absent